APA

Villaverde-Hueso A., de la Paz M. P., Martín-Arribas M. C., Sánchez-Valle E., Ramírez-González A. & Biairdi P. (20081211). Prevalence of scleroderma in Spain: an approach for estimating rare disease prevalence using a disease model. : Pharmacoepidemiology and drug safety.

Chicago

Villaverde-Hueso A, de la Paz M Posada, Martín-Arribas M C, Sánchez-Valle E, Ramírez-González A and Biairdi P. 20081211. Prevalence of scleroderma in Spain: an approach for estimating rare disease prevalence using a disease model. : Pharmacoepidemiology and drug safety.

Harvard

Villaverde-Hueso A., de la Paz M. P., Martín-Arribas M. C., Sánchez-Valle E., Ramírez-González A. and Biairdi P. (20081211). Prevalence of scleroderma in Spain: an approach for estimating rare disease prevalence using a disease model. : Pharmacoepidemiology and drug safety.

MLA

Villaverde-Hueso A, de la Paz M Posada, Martín-Arribas M C, Sánchez-Valle E, Ramírez-González A and Biairdi P. Prevalence of scleroderma in Spain: an approach for estimating rare disease prevalence using a disease model. : Pharmacoepidemiology and drug safety. 20081211.